Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

12 results
Display

Is Cross-reactivity with Nontuberculous Mycobacteria a Systematic Problem in the Xpert MTB/RIF Assay?

Huh HJ, Song DJ, Ki CS, Lee NY

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):88-89.
  • doi: 10.4046/trd.2018.0075
No abstract available.
High-Flow Nasal Cannula Oxygen Delivery during Bronchoalveolar Lavage: A Question of Methodology Influence?

Singha SK, Esquinas A

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):86-87.
  • doi: 10.4046/trd.2018.0058
No abstract available.
Clinical Effectiveness of High-Flow Nasal Cannula in Hypoxaemic Patients during Bronchoscopic Procedures

Chung SM, Choi JW, Lee YS, Choi JH, Oh JY, Min KH, Hur GY, Lee SY, Shim JJ, Kang KH

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):81-85.
  • doi: 10.4046/trd.2017.0104
BACKGROUND: Bronchoscopy is a useful diagnostic and therapeutic tool. However, the clinical use of high-flow nasal cannula (HFNC) in adults with acute respiratory failure for diagnostic and invasive procedures has...
Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma

Kang JY, Kim IK, Hur J, Kim SC, Lee SY, Kwon SS, Kim YK

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):71-80.
  • doi: 10.4046/trd.2018.0049
BACKGROUND: Efficacy and safety of tiotropium bromide, a muscarinic receptor antagonist, in treatment of asthma have been reported. However, its effect on airway remodeling in chronic asthma of the elderly...
Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma

Kim SY, Myung JK, Kim HR, Na II, Koh JS, Baek HJ, Kim CH

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):62-70.
  • doi: 10.4046/trd.2018.0004
BACKGROUND: Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancers have emerged as key predictive biomarkers in EGFR tyrosine kinase inhibitor (TKI) treatment. However, a few patients with...
Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome

Na YS, Jang S, Hong S, Oh YM, Lee SD, Lee JS

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):53-61.
  • doi: 10.4046/trd.2018.0045
BACKGROUND: Antiphospholipid antibody syndrome (APS), an important cause of acquired thrombophilia, is diagnosed when vascular thrombosis or pregnancy morbidity occurs with persistently positive antiphospholipid antibodies (aPL). APS is a risk...
The Effects of Retinoic Acid and MAPK Inhibitors on Phosphorylation of Smad2/3 Induced by Transforming Growth Factor β1

Lee SH, Shin JH, Shin MH, Kim YS, Chung KS, Song JH, Kim SY, Kim EY, Jung JY, Kang YA, Chang J, Park MS

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):42-52.
  • doi: 10.4046/trd.2017.0111
BACKGROUND: Transforming growth factor β (TGF-β), retinoic acid (RA), p38 mitogen-activated protein kinase (MAPK), and MEK signaling play critical roles in cell differentiation, proliferation, and apoptosis. We investigated the effect...
Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation

Kim TH, Rhee CK, Oh YM

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):35-41.
  • doi: 10.4046/trd.2018.0050
BACKGROUND: Pulmonary tuberculosis can result in anatomical sequelae, and cause airflow limitation. However, there are no treatment guidelines for patients with a tuberculosis-destroyed lung. Recently, indacaterol effectiveness in chronic obstructive...
Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea

Kim C, Kim Y, Yang DW, Rhee CK, Kim SK, Hwang YI, Park YB, Lee YM, Jin S, Park J, Hahm CR, Park CH, Park SY, Jung CK, Kim YI, Lee SH, Yoon HK, Lee JH, Lim SY, Yoo KH

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):27-34.
  • doi: 10.4046/trd.2018.0035
BACKGROUND: Understanding the burden of disease is important to establish cost-effective treatment strategies and to allocate healthcare resources appropriately. However, little reliable information is available regarding the overall economic burden...
Treatment of Mycobacterium avium Complex Pulmonary Disease

Kwon YS, Koh WJ, Daley CL

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):15-26.
  • doi: 10.4046/trd.2018.0060
The pathogen Mycobacterium avium complex (MAC) is the most common cause of nontuberculous mycobacterial pulmonary disease worldwide. The decision to initiate long-term antibiotic treatment is difficult for the physician due...
Sepsis: Early Recognition and Optimized Treatment

Kim HI, Park S

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):6-14.
  • doi: 10.4046/trd.2018.0041
Sepsis is a life-threatening condition caused by infection and represents a substantial global health burden. Recent epidemiological studies showed that sepsis mortality rates have decreased, but that the incidence has...
Smoking Cessation Strategies Targeting Specific Populations

Chun EM

  • Tuberc Respir Dis.
  • 2019 Jan;82(1):1-5.
  • doi: 10.4046/trd.2017.0101
Quitting smoking helps smokers maintain their health and extend their lifespan by 10 or more years. Treatment strategies for smoking cessation should be tailored to individual smokers with special needs...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr